Bioklone

Chennai, India Founded: 2006 • Age: 20 yrs
Bioservice provider specializing in the development of customized antibodies and assays for research, diagnostic, and pharmaceutical applications

About Bioklone

Bioklone is a Healthcare company based in Chennai (India) founded in 2006 by T Venkataramani and Rajeshwari Krishnamurthy. Bioservice provider specializing in the development of customized antibodies and assays for research, diagnostic, and pharmaceutical applications. Its Indian entity Bioklone Biotech Private Limited reported revenue of β‚Ή97 Lakh. Its focus areas include Biopharma Outsourcing and Diversified.

Company details

Bioklone Biotech Private Limited is a bioservice provider that specializes in the development of customized antibodies and assays for research, diagnostic, and pharmaceutical applications. The company uses a range of techniques, including polyclonal antibody development, assay development, and cell viability and proliferation assays, to support various industries. With a focus on customized solutions, Bioklone works with clients to develop antibodies and assays that meet their specific needs.

  • Headquarters Chennai, India
  • Founders T Venkataramani, Rajeshwari Krishnamurthy
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bioklone.com
  • Social LinkedIn Facebook
  • Legal Name Bioklone Biotech Private Limited
  • Date of Incorporation 12 Mar, 2013
  • Jurisdiction Chennai, Tamil Nadu, India
Key Metrics
  • Annual Revenue
    ₹97 Lakh

    FY 2024 · +23% YoY

  • Net Profit
    ₹3.4 Lakh

    FY 2024 · 3% margin

  • EBITDA
    ₹6.1 Lakh

    FY 2024 · 6% margin

Board of directors of Bioklone Biotech Private Limited (Bioklone)

Bioklone Biotech Private Limited is the primary company behind Bioklone. The board of Bioklone Biotech Private Limited currently have 2 directors; the longest-serving is Theerthanarayana Venkataramani, appointed in 2013.

DirectorDesignationAppointedTenureEntity
Theerthanarayana Venkataramani
DIN 02970605
Director12 Mar 201313 yrs 8 moBioklone Biotech Private Limited
Krishnamurthy Rajeshwari
DIN 06509115
Managing Director12 Mar 201313 yrs 8 moBioklone Biotech Private Limited

People of Bioklone

2 people are tracked at Bioklone (2 in leadership).

NameRoleGroup
T Venkataramani
Co-Founder & DirectorLeadership
Founder and Managing DirectorLeadership
Premium access

Complete people profiles for Bioklone

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Bioklone

Figures of Bioklone Biotech Private Limited, the primary company behind Bioklone, for FY 2024. Revenue was ₹97 Lakh (+23% year on year). Net profit was ₹3.4 Lakh (3% margin). EBITDA was ₹6.1 Lakh (6% margin). Revenue has grown at a compounded annual rate of +28% over three years and +10% over five years.

  • ₹97 LakhRevenue · FY 2024 · +23% YoY
  • ₹3.4 LakhNet profit · 3% margin
  • ₹6.1 LakhEBITDA · 6% margin
  • ₹1 LakhPaid-up capital
  • +28%Revenue CAGR, 3 years
  • +10%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bioklone Biotech Private Limited are on its company page.

Premium access

Detailed financial statements for Bioklone

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Bioklone

The website of Bioklone (bioklone.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Bioklone (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bioklone

Bioklone was founded in 2006.

Bioklone is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

The primary company behind Bioklone, Bioklone Biotech Private Limited, reported revenue of β‚Ή97 Lakh for FY 2024, up 23% year on year.

Bioklone Biotech Private Limited is a bioservice provider that specializes in the development of customized antibodies and assays for research, diagnostic, and pharmaceutical applications. The company uses a range of techniques, including polyclonal antibody development, assay development, and cell viability and proliferation assays, to support various industries. With a focus on customized solutions, Bioklone works with clients to develop antibodies and assays that meet their specific needs.

Bioklone operates through Bioklone Biotech Private Limited.

The legal entities of Bioklone currently have 2 directors, including Theerthanarayana Venkataramani, Krishnamurthy Rajeshwari.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available